Penicillins Or Streptomycins Medicaments Market

The article provides a comprehensive analysis of the global market for penicillins, streptomycins, and derivatives, projecting an upward consumption trend with a CAGR of +6.2% in volume and +7.7% in value terms by 2030. Consumption, production, import, and export trends are examined, with insights into key players and country performances. Market dynamics, growth rates, consumption patterns, and price trends are all covered in detail, offering a valuable overview for industry stakeholders.

Market Forecast

Driven by increasing demand for medicaments of penicillins, streptomycins or derivatives thereof worldwide, the market is expected to continue an upward consumption trend over the next eight years. Market performance is forecast to retain its current trend pattern, expanding with an anticipated CAGR of +6.2% for the period from 2022 to 2030, which is projected to bring the market volume to 729K tons by the end of 2030.

In value terms, the market is forecast to increase with an anticipated CAGR of +7.7% for the period from 2022 to 2030, which is projected to bring the market value to $25.7B (in nominal prices) by the end of 2030.

Consumption

World Consumption of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

In 2022, approx. 452K tons of medicaments of penicillins, streptomycins or derivatives thereof were consumed worldwide; which is down by -11.6% against the year before. Over the period under review, consumption, however, showed a strong expansion. Global consumption peaked at 644K tons in 2019; however, from 2020 to 2022, consumption remained at a lower figure.

The global penicillins or streptomycins medicaments market size fell to $14.2B in 2022, waning by -5.8% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption, however, enjoyed strong growth. Over the period under review, the global market attained the maximum level at $19.5B in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Consumption By Country

The countries with the highest volumes of consumption in 2022 were Turkey (108K tons), China (63K tons) and the United States (40K tons), with a combined 47% share of global consumption.

From 2012 to 2022, the biggest increases were recorded for Turkey (with a CAGR of +45.3%), while consumption for the other global leaders experienced more modest paces of growth.

In value terms, Turkey ($2.9B), the United States ($2.2B) and Indonesia ($686M) were the countries with the highest levels of market value in 2022, with a combined 41% share of the global market.

Turkey, with a CAGR of +38.6%, recorded the highest rates of growth with regard to market size among the main consuming countries over the period under review, while market for the other global leaders experienced more modest paces of growth.

In 2022, the highest levels of penicillins or streptomycins medicaments per capita consumption was registered in Turkey (1,261 kg per 1000 persons), followed by Spain (217 kg per 1000 persons), the UK (137 kg per 1000 persons) and the United States (118 kg per 1000 persons), while the world average per capita consumption of penicillins or streptomycins medicaments was estimated at 57 kg per 1000 persons.

From 2012 to 2022, the average annual growth rate of the penicillins or streptomycins medicaments per capita consumption in Turkey amounted to +43.5%. In the other countries, the average annual rates were as follows: Spain (+9.2% per year) and the UK (+3.4% per year).

Production

World Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Global penicillins or streptomycins medicaments production contracted to 449K tons in 2022, falling by -12.4% on the previous year. Overall, production, however, recorded resilient growth. The growth pace was the most rapid in 2018 with an increase of 45% against the previous year. Over the period under review, global production reached the peak volume at 640K tons in 2019; however, from 2020 to 2022, production stood at a somewhat lower figure.

In value terms, penicillins or streptomycins medicaments production reached $10.5B in 2022 estimated in export price. In general, the total production indicated a notable increase from 2012 to 2022: its value increased at an average annual rate of +3.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -31.7% against 2019 indices. The pace of growth appeared the most rapid in 2018 with an increase of 47% against the previous year. Global production peaked at $15.4B in 2019; however, from 2020 to 2022, production failed to regain momentum.

Production By Country

The countries with the highest volumes of production in 2022 were Turkey (109K tons), China (81K tons) and India (36K tons), together accounting for 50% of global production.

From 2012 to 2022, the most notable rate of growth in terms of production, amongst the leading producing countries, was attained by Turkey (with a CAGR of +47.2%), while production for the other global leaders experienced more modest paces of growth.

Imports

World Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

In 2022, approx. 105K tons of medicaments of penicillins, streptomycins or derivatives thereof were imported worldwide; picking up by 13% on the previous year. The total import volume increased at an average annual rate of +2.1% from 2012 to 2022; the trend pattern remained relatively stable, with only minor fluctuations being recorded throughout the analyzed period. Over the period under review, global imports attained the maximum at 112K tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, penicillins or streptomycins medicaments imports expanded markedly to $3.8B in 2022. Overall, imports, however, continue to indicate a pronounced decline. Global imports peaked at $4.6B in 2012; however, from 2013 to 2022, imports stood at a somewhat lower figure.

Imports By Country

The purchases of the twelve major importers of medicaments of penicillins, streptomycins or derivatives thereof, namely the United States, Nigeria, Egypt, Germany, Saudi Arabia, Spain, Belgium, the UK, Russia, France, Vietnam and Slovenia, represented more than third of total import.

From 2012 to 2022, the biggest increases were recorded for Egypt (with a CAGR of +17.9%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($463M), Egypt ($339M) and Saudi Arabia ($206M) were the countries with the highest levels of imports in 2022, with a combined 27% share of global imports.

Among the main importing countries, Egypt, with a CAGR of +18.5%, saw the highest growth rate of the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices By Country

In 2022, the average penicillins or streptomycins medicaments import price amounted to $36,145 per ton, with a decrease of -4.1% against the previous year. In general, the import price recorded a noticeable decline. The most prominent rate of growth was recorded in 2021 when the average import price increased by 14%. Over the period under review, average import prices reached the maximum at $54,324 per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United States ($60,374 per ton), while Nigeria ($10,177 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+1.5%), while the other global leaders experienced more modest paces of growth.

Exports

World Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

In 2022, the amount of medicaments of penicillins, streptomycins or derivatives thereof exported worldwide expanded sharply to 102K tons, picking up by 8.4% against the previous year. Over the period under review, exports, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 with an increase of 9.4%. The global exports peaked at 122K tons in 2014; however, from 2015 to 2022, the exports remained at a lower figure.

In value terms, penicillins or streptomycins medicaments exports expanded modestly to $3.4B in 2022. In general, exports, however, continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2018 with an increase of 7%. Over the period under review, the global exports reached the peak figure at $3.8B in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

Exports By Country

India (20K tons) and China (19K tons) represented the major exporters of medicaments of penicillins, streptomycins or derivatives thereof in 2022, resulting at approx. 20% and 19% of total exports, respectively. Austria (11K tons) held an 11% share (based on physical terms) of total exports, which put it in second place, followed by Italy (7.1%). Portugal (3.6K tons), Canada (3.5K tons), Slovenia (3.4K tons), France (3.3K tons), the UK (2.8K tons), Belgium (2.7K tons), the Netherlands (2.3K tons) and Germany (1.8K tons) took a little share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Portugal (with a CAGR of +49.5%), while the other global leaders experienced more modest paces of growth.

In value terms, India ($575M), Austria ($358M) and Italy ($299M) constituted the countries with the highest levels of exports in 2022, with a combined 36% share of global exports. The UK, China, France, Belgium, Slovenia, Canada, Portugal, the Netherlands and Germany lagged somewhat behind, together comprising a further 42%.

Portugal, with a CAGR of +23.0%, saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices By Country

In 2022, the average penicillins or streptomycins medicaments export price amounted to $33,176 per ton, shrinking by -4.4% against the previous year. Over the period under review, the export price, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when the average export price increased by 11%. Over the period under review, the average export prices hit record highs at $35,454 per ton in 2019; however, from 2020 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was the UK ($100,921 per ton), while China ($13,639 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (+8.3%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform